Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy
DOI:
https://doi.org/10.17161/rrnmf.v3i2.18133Keywords:
letterMetrics
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Richard J. Barohn, Jeffery Allen , David Avila, Alexandru Barboi, Suur Biliciler , Charles Abrams , Thomas Brannagan III, Michael Cartwright , Nizar Chahin, Jasvinder Chawla, Miguel Chuquilin, Michael Collins, Anahita Deboo, John England, Joseph Americo Fernandes, Miriam Friemer , Stefanie Geisler, Steven Herskovitz , Neil Holland, Carlayne Jackson, Vern Juel , David Lacomis, Maxwell Levy, Rabia Malik , Daniela Menichella, Sharon Nations, Amanda Peltier, Michael Pulley, Kourosh Rezania, Jessica Robinson-Papp, Katherine Ruzhansky, Khema Sharma, Amro Stino, Xiaowei Su, Andrea Swenson , Pariwat Thaisetthawatkul, Sujata Thawani, Rebecca Traub
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.